RA
CNCE

Royce & Associates’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Royce & Associates’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,425
Closed -$21K – 1219
2018
Q3 		$21K Buy
1,425
+758
+114% +$11.2K ﹤0.01% 1150
2018
Q2 		$11K Buy
667
+344
+107% +$5.67K ﹤0.01% 1200
2018
Q1 		$7K Buy
+323
New +$7K ﹤0.01% 1228